Self-assembly regulated anticancer activity of platinum coordinated selenomethionine
- PMID: 29223531
- DOI: 10.1016/j.biomaterials.2017.12.001
Self-assembly regulated anticancer activity of platinum coordinated selenomethionine
Abstract
It is urgently desired that self-assembly methods can be used to develop smart nanomedicines with adjustable anticancer activity and concise structure. Herein, we design carrier-free small molecule assemblies of platinum coordinated selenomethionine, which exhibit adjustable anticancer activity regulated by their self-assembly behaviors. The small molecule assemblies are prepared by coordination of selenomethionine esters with cisplatin. Their self-assembly behaviors can be tuned by esterification between selenomethionine and alcohols with different alkyl lengths, which results in adjustable anticancer activities. The coordination assemblies exhibit high anticancer activity as well as low side effects. Mechanistic studies indicate that they can consume glutathione (GSH) and therefore induce high level of reactive oxygen species (ROS) in cancer cells, which further lead to cell apoptosis. Our findings provide new strategies and insights in developing small molecule assemblies for cancer treatment.
Keywords: Anticancer; Coordination; Platinum; Selenium; Self-assembly.
Copyright © 2017 Elsevier Ltd. All rights reserved.
Similar articles
-
Significant effects of counteranions on the anticancer activity of iridium(iii) complexes.Chem Commun (Camb). 2018 Apr 26;54(35):4421-4424. doi: 10.1039/c8cc01326h. Chem Commun (Camb). 2018. PMID: 29648559
-
Platinum(IV) complexes conjugated with chalcone analogs as dual targeting anticancer agents: In vitro and in vivo studies.Bioorg Chem. 2020 Dec;105:104430. doi: 10.1016/j.bioorg.2020.104430. Epub 2020 Oct 27. Bioorg Chem. 2020. PMID: 33171407
-
Dinuclear orthometallated gold(I)-gold(III) anticancer complexes with potent in vivo activity through an ROS-dependent mechanism.Metallomics. 2021 Jul 15;13(7):mfab039. doi: 10.1093/mtomcs/mfab039. Metallomics. 2021. PMID: 34165566
-
Recent advances in ruthenium and platinum based supramolecular coordination complexes for antitumor therapy.Colloids Surf B Biointerfaces. 2019 Oct 1;182:110373. doi: 10.1016/j.colsurfb.2019.110373. Epub 2019 Jul 26. Colloids Surf B Biointerfaces. 2019. PMID: 31376689 Review.
-
Anticancer metallotherapeutics in preclinical development.Curr Med Chem. 2011;18(31):4738-52. doi: 10.2174/092986711797535308. Curr Med Chem. 2011. PMID: 21919843 Review.
Cited by
-
Selenium-Containing Agents Acting on Cancer-A New Hope?Pharmaceutics. 2022 Dec 28;15(1):104. doi: 10.3390/pharmaceutics15010104. Pharmaceutics. 2022. PMID: 36678733 Free PMC article. Review.
-
Seleno-Warfare against Cancer: Decoding Antitumor Activity of Novel Acylselenoureas and Se-Acylisoselenoureas.Pharmaceutics. 2024 Feb 14;16(2):272. doi: 10.3390/pharmaceutics16020272. Pharmaceutics. 2024. PMID: 38399326 Free PMC article.
-
Selenium-enriched plant foods: Selenium accumulation, speciation, and health functionality.Front Nutr. 2023 Feb 6;9:962312. doi: 10.3389/fnut.2022.962312. eCollection 2022. Front Nutr. 2023. PMID: 36815133 Free PMC article. Review.
-
Seleno-amino Acid Metabolism Reshapes the Tumor Microenvironment: from Cytotoxicity to Immunotherapy.Int J Biol Sci. 2024 May 5;20(7):2779-2789. doi: 10.7150/ijbs.95484. eCollection 2024. Int J Biol Sci. 2024. PMID: 38725849 Free PMC article. Review.
-
GSH-sensitive Pt(IV) prodrug-loaded phase-transitional nanoparticles with a hybrid lipid-polymer shell for precise theranostics against ovarian cancer.Theranostics. 2019 Jan 30;9(4):1047-1065. doi: 10.7150/thno.29820. eCollection 2019. Theranostics. 2019. PMID: 30867815 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources